Australia's Sigma Pharmaceuticals (SIP.AX) has received three bids for its Herron drugs arm and three bids for its Orphan Australia drugs business, as it seeks an improved bid for the entire company from South Africa's Aspen Pharmacare (APNJ.J). Report